2025 Regular Session • Florida Legislature
S0876: Chimeric Antigen Receptor T-cell Therapy
Legislative Summary
Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/19/2025
Filed
Senate
2/28/2025
Referred to Banking and Insurance; Judiciary; Rules
Senate
3/4/2025
Introduced
Senate
Status Information
Current Status
Introduced(2/19/2025)
Chamber
Senate
Committee
Banking and Insurance(Senate)
Sponsors
Democrat: 1
Primary Sponsor
Lori Berman
Democrat